Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hideaki Hashimoto
Institutions:
Tohoku Medical and Pharmaceutical University Hospital,
Tohoku Medical and Pharmaceutical University
Observed institutions:
Tohoku Medical and Pharmaceutical University Hospital,
Tohoku Medical and Pharmaceutical University
ORCID:
0000-0002-5694-5236
Observed ORCID:
0000-0002-5694-5236
OpenAlex ID:
A5128656683
Comparison of SGLT2 Inhibitors for New‐Onset Proteinuria Risk in Patients With Type 2 Diabetes and Preserved Kidney Function
2026
·
Hiroki Nobayashi
, Michihiro Satoh
, et al.
·
Diabetes Obesity and Metabolism
·
1
Near-Complete Loss and Functional Reversibility of Sodium-Glucose Cotransporter 2 in Membranous Nephropathy With Severe Tubulointerstitial Damage: A Case Report
2026
·
Ayaka Kamada
, Takuo Hirose
, et al.
·
Kidney International Case Reports
Effects of individual sodium-glucose cotransporter-2 inhibitors on all-cause mortality in patients with diabetic kidney disease
2026
·
Hiroki Nobayashi
, Michihiro Satoh
, et al.
·
Clinical and Experimental Nephrology
Author response for "Comparison of SGLT2 inhibitors for new-onset proteinuria risk in patients with type 2 diabetes and preserved kidney function"
2026
·
Hiroki Nobayashi
, Michihiro Satoh
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type